RM

Rajiv Malhotra

Active Director Director DIN 08282319
DIN 08282319 First appointment Nov 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value •••• Premium profile

About Rajiv Malhotra

Data last updated:

Rajiv Malhotra is a Director at Wenslay Biotech Private Limited (since 2018). The company operates in Pharma. Wenslay Biotech Private Limited reported revenue of ₹1.01 Cr (FY 2025).

DIN 08282319
Primary Designation Director
Industry Pharma
First Appointment 19 Nov 2018
Oldest Company Age 7 yrs
Largest company Wenslay Biotech Private Limited · ₹1.01 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Wenslay Biotech Private Limited U52599HR2018PTC076951
Director19 Nov 20182018₹1.01 Cr (FY 2025)Active

Board colleagues of Rajiv Malhotra

Directorship timeline

Open interactive timeline →
Wenslay Biotech Private Limited
Premium access

Shareholding and investment profile for Rajiv Malhotra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajiv Malhotra

Rajiv Malhotra currently holds 1 directorship: Wenslay Biotech Private Limited (Director, since 19 Nov 2018, revenue ₹1.01 Cr (FY 2025)).

Rajiv Malhotra was first appointed on 19 Nov 2018 as Director at Wenslay Biotech Private Limited.

The current boards of Rajiv Malhotra's companies include Anshu Arora (Wenslay Biotech Private Limited), Nikhil Malhotra (Wenslay Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available